Winch Advisory Services’s GSK GSK Stock Holding History

Winch Advisory Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.2K	Buy	652 +125	+24%	+$6.61K	0.01%	225
2026 Q1	$29.1K	Buy	527 +4	+0.8%	+$217	0.01%	221
2025 Q4	$25.6K	Buy	523 +5	+1%	+$233	0.01%	230
2025 Q3	$22.3K	Buy	518 +6	+1%	+$234	0.01%	232
2025 Q2	$19.7K	Buy	512 +6	+1%	+$229	﹤0.01%	236
2025 Q1	$19.6K	Hold	506	–	–	0.01%	228
2024 Q4	$17.1K	Buy	+506	New	+$18.2K	﹤0.01%	238
2023 Q3	–	Sell	-783	Closed	-$28K	–	433
2023 Q2	$28K	Buy	783 +6	+0.8%	+$215	0.01%	174
2023 Q1	$28K	Buy	777 +8	+1%	+$280	0.01%	167
2022 Q4	$27K	Buy	769 +9	+1%	+$300	0.01%	163
2022 Q3	$22K	Buy	760 +6	+0.8%	+$227	0.01%	164
2022 Q2	$41K	Buy	754 +8	+1%	+$442	0.02%	132
2022 Q1	$41K	Buy	+746	New	+$40.5K	0.01%	144
2021 Q4	–	Sell	-727	Closed	-$35K	–	486
2021 Q3	$35K	Buy	727 +9	+1%	+$452	0.01%	156
2021 Q2	$36K	Buy	718 +12	+2%	+$577	0.01%	148
2021 Q1	$32K	Buy	706 +9	+1%	+$409	0.01%	145
2020 Q4	$32K	Buy	697 +9	+1%	+$413	0.01%	124
2020 Q3	$32K	Sell	688 -163	-19%	-$8.17K	0.01%	117
2020 Q2	$43K	Buy	851 +90	+12%	+$4.62K	0.02%	100
2020 Q1	$36K	Sell	761 -71	-9%	-$3.79K	0.02%	102
2019 Q4	$49K	Buy	832 +9	+1%	+$501	0.02%	114
2019 Q3	$44K	Buy	823 +9	+1%	+$463	0.02%	111
2019 Q2	$41K	Buy	814 +12	+1%	+$602	0.02%	122
2019 Q1	$42K	Sell	802 -46	-5%	-$2.3K	0.02%	124
2018 Q4	$41K	Sell	848 -182	-18%	-$8.96K	0.02%	108
2018 Q3	$52K	Buy	1,030 +8	+0.8%	+$406	0.03%	101
2018 Q2	$51K	Sell	1,022 -32	-3%	-$1.61K	0.03%	111
2018 Q1	$52K	Sell	1,054 -95	-8%	-$4.42K	0.03%	110
2017 Q4	$51K	Buy	1,149 +92	+9%	+$4.25K	0.03%	98
2017 Q3	$54K	Buy	1,057 +9	+0.9%	+$457	0.04%	90
2017 Q2	$56K	Buy	1,048 +150	+17%	+$8K	0.04%	107
2017 Q1	$47K	Buy	898 +9	+1%	+$457	0.03%	112
2016 Q4	$43K	Buy	889 +9	+1%	+$445	0.03%	101
2016 Q3	$47K	Buy	880 +9	+1%	+$493	0.04%	94
2016 Q2	$47K	Buy	871 +22	+3%	+$1.16K	0.06%	82
2016 Q1	$43K	Buy	849 +11	+1%	+$548	0.07%	47
2015 Q4	$42K	Buy	838 +12	+1%	+$612	0.05%	57
2015 Q3	$40K	Buy	826 +11	+1%	+$573	0.06%	56
2015 Q2	$42K	Sell	815 -15,736	-95%	-$886K	0.02%	113
2015 Q1	$955K	Buy	+16,551	New	+$949K	0.56%	42
2014 Q4	–	Sell	-87,281	Closed	-$5.01M	–	97
2014 Q3	$5.01M	Buy	87,281 +86,624	+13,185%	+$5.31M	3.22%	10
2014 Q2	$44K	Buy	657 +10	+2%	+$677	0.03%	91
2014 Q1	$43K	Buy	+647	New	+$43.7K	0.03%	107

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Winch Advisory Services's GSK Position: Q2 2026 in Review

Winch Advisory Services increased its GSK (GSK) stake by 24% in Q2 2026, buying an estimated $6.61K and bringing the position to 652 shares worth $34.2K. The position accounts for 0.01% of the portfolio, ranked #225.

Winch Advisory Services first reported a position in GSK in Q1 2014 and has held it in 43 quarters since. The position peaked at $5.01M in Q3 2014. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Winch Advisory Services held 652 shares of GSK worth $34.2K as of Q2 2026.
Winch Advisory Services bought 125 GSK shares in Q2 2026, an estimated $6.61K.
GSK made up 0.01% of Winch Advisory Services's portfolio in Q2 2026, its #225 holding.
Winch Advisory Services first reported a position in GSK in Q1 2014 and has held it in 43 quarters since.
Winch Advisory Services's GSK position peaked at $5.01M in Q3 2014.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Winch Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.